Impact of allergic rhinitis treatment on quality of life

PharmacoEconomics

Volumn 19, Issue 9, 2001, Pages 891-899

  Tripathi, A ^a   Patterson, R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BROMPHENIRAMINE; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; FEXOFENADINE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; NEDOCROMIL SODIUM; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

ALLERGIC RHINITIS; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SIDE EFFECT;

EID: 0034796181     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119090-00001     Document Type: Review

References (88)

1. Allergic and nonallergic rhinitis
2. Hayfever, a post-industrial revolution epidemic: A history of its growth during the 19th century
3. Asthma and allergic rhinitis in Swedish conscripts
4. Longitudinal changes in skin test reactivity in a community population sample
5. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: The Midspan family study surveys of parents and offspring
6. Increase of asthma and allergic rhinitis prevalence in young Italian men
7. Diagnosis and management of rhinitis: Complete Guidelines of the Joint Task Force on practice parameters in allergy, asthma, and immunology
8. A cost of illness study of allergic rhinitis in the United States
9. The MOS 36-item short-form health survey
10. The sickness impact profile: Development of an outcome measure for health care
11. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire
12. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
13. Assessment of quality of life in adolescents with allergic rhinoconjuncitivitis: Development and testing of a questionnaire for clinical trials
14. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires
15. Multicenter, double-blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children
16. Nasal pharmacodynamics of brompheniramine in perennial rhinitis
17. Safety and efficacy of loratidine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis
18. Multicentre doubleblind comparison of terfenadine and cetirizine in patients with seasonal allergic rhinitis
19. Performance effects of antihistamines
20. Impairment of function by antihistamines
21. Antihistamines and driving performance: The Netherlands
22. Sedative effects of antihistamines
23. Sedative effects of antihistamines: Safety, performance, learning, and quality of life
24. Seasonal allergic rhinitis and antihistamine effects on children's learning
25. Effects of loratidine and cetirizine on actual driving a psychometric test performance, and EEG during driving
26. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects
27. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects of highway driving, psychometric test performance and daytime sleepiness
28. Antihistamines: Is there anything safe to prescribe?
29. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratidine and promethazine on cognitive and psychomotor function
30. Terfenadine-ketoconazole interaction
31. Astemizole-induced cardiac conduction disturbances in a child
32. Loratidine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations
33. Effects of cetirizine and erythromycin, alone and in combination on QT interval and pharmacokinetics in healthy subjects
34. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis
35. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French Version of the SF-36 questionnaire
36. Once-daily fexofenadine HCL improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
37. Efficacy and safety of loratidine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
38. Levocarbastine: An effective topical treatment of allergic rhinoconjunctivitis
39. A double-blind controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis
40. The effect of azelastine on neutrophil and eosinophil generation of superoxide
41. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity
42. Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis
43. New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: Comparative assessment of safety, tolerability, and efficacy
44. A comparative trial of intra-nasal beclomethasone dipropionate and sodium cromoglycate in patients with chronic perennial rhinitis
45. Efficacy of beclomethasone nasal solution, flunisollde, and cromolyn in relieving symptoms of ragweed allergy
46. Comparison of triamcinolone acetonide nasal inhaler with astemizole in treatment of ragweed-induced allergic rhinitis
47. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis
48. Effect of topical corticosteroids on seasonally induced increases in nasal mast cells
49. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge
50. Use of nasal steroids in managing allergic rhinitis
51. Nasal septal perforation in patients using intranasal beclomethasone propionate (BDP)
52. Nasal septal perforation associated with topical corticosteroid therapy
53. Long term follow-up of intra-nasal beclomethasone treatment: A clinical and histologic study
54. Long term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Morphological studies and conclusions
55. Intranasal fluocortin butyl in patients with perennial rhinitis: A 12-month efficacy and safety study including nasal biopsy
56. An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray on long-term growth in children
57. Short term growth in children with allergic rhinitis treated with oral antihistamine depot and intranasal glucocorticosteroids
58. Intranasal fluticasone propionate: A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis
59. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis
60. Long-term safety of budesonide nasal aerosol: A 5.5-year follow-up study
61. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis
62. Aqueous beclomethasone dipropionate nasal spray: Regular versus 'as required' use in the treatment of seasonal allergic rhinitis
63. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis
64. Cromolyn sodium: A review
65. A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis
66. Sodium cromoglycate eye drops: Regular versus 'as needed' use in the treatment of seasonal allergic conjunctivitis
67. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effect on their symptoms, quality of life, and nasal cytology
68. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications
69. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar
70. Comparative efficacy and safety of a once-daily loratidine-pseudoephedrine combination versus components alone and placebo in the management of seasonal allergic rhinitis
71. Long-term clinical efficacy of grass-pollen immunotherapy
72. A double-blind study of the discontinuation of ragweed immunotherapy
73. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patient swith grass pollen rhinitis
74. Immunotherapy past and present
75. Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis
76. First-line treatment of seasonal (ragweed) rhinoconjunctivitis: A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine
77. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratidine, alone and in combination, for the treatment of seasonal allergic rhinitis
78. A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis
79. A comparative study of dexchlorphenirmaine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis
80. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis
81. Comparison of flunisolide nasal spray and terfenadine tablets in hay fever
82. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhintis
83. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis
84. A comparative study of beclomethasone dipropionate aqueous spray with terfenadine tablets in seasonal allergic rhinitis
85. Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate
86. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination